Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0095
+0.0004 (4.68%)
Dec 22, 2025, 9:30 AM EST
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $9.28 million as of December 22, 2025. Its market cap has increased by 0.97% in one year.
Market Cap
9.28M
Enterprise Value
12.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 9.28M, a decrease of -58.48%. That is a compound annual growth rate of -4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 9.28M | -21.12% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | 9.75M | 1,242.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 198.84M |